安捷利實業(01639.HK):持股合資公司斥5.5億美元收購印刷電路板公司
格隆匯1月23日丨安捷利實業(01639.HK)公佈,於1月20日,買方安捷利美維電子(廈門)有限責任公司(公司間接持有6%股權的合資公司)與賣方及賣方的最終控股股東迅達科技公司訂立股權購買協議,據此,買方收購而賣方出售目標公司的全部股權,代價為5.5億美元。
公告顯示,目標公司為廣州美維電子有限公司、上海美維電子有限公司、上海美維科技有限公司及上海凱思爾電子有限公司。
目標公司在行業內處於技術領先地位,與全球客户建立了長期和穩定的合作關係。目標公司主要從事硬性印刷電路板產品,包括類載板,高密度互聯板,積體電路封裝基板及相關電子裝聯、微電子及光電產品的研發、生產及銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.